Tumor antigen peptides derived from cyclophilin B

Details Tumor antigen peptides derived from cyclophilin B Tumor antigen peptides derived from cyclophilin B

2008-05-06

2008-05-06

Yu, Misook (Department: 1642)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S184100, C435S325000

Reexamination Certificate

active

11227238

ABSTRACT:
Tumor antigen peptides derived from cyclophilins or derivatives thereof having the functionally equivalent properties; medicaments, prophylactics, or diagnostics for tumors comprising as an active ingredient such tumor antigen peptides or derivatives thereof, cyclophilins or partial polypeptides thereof, or genes encoding said cyclophilins or partial polypeptides thereof; in vitro use of the above substances for treatment of tumors; and antibodies against the above tumor antigen peptides derived from cyclophilins or derivatives thereof are provided.

REFERENCES:
patent: 0326067 (1989-08-01), None
patent: 0326067 (1989-08-01), None
patent: 8500106 (1996-01-01), None
patent: 9151200 (1997-06-01), None
Miyake et al., Jun. 1997;157(6):2351-5.
Lontung, Chao et al.,Journal of Investigative Dermatology,vol. 102, No. 4, p. 589 (1994), XP001033799.
G. Alkhatib et al.,Immunology,vol. 92, No. 2, pp. 173-179 (1997), XP001033900.
Shinya Gomi et al.,Journal of Immunology,vol. 163, pp. 4994-5004 (1999), XP002948569.
Shinchijo et al.,J. Exp. Med.,vol. 187, No. 3, pp. 277-288 (1998).
E.R. Price et al., Proc. Natl. Acad. Sci., USA, vol. 88, pp. 1903-1907 (1991).
H.G. Rammensee et al.,Immunogenetics,vol. 41, pp. 178-228 (1995).
H. Schneider et al.,Biochemistry,vol. 33, pp. 8218-8224 (1994).
Ralph T. Kubo et al.,Journal of Immunology,vol. 152, p. 3913 (1994).
L. Rivoltini et al.,Journal of Immunology,vol. 154, pp. 2257-2265 (1995).
A. Kondo et al.,Journal of Immunology,vol. 155, pp. 4307-4312 (1995).
T. Sudo et al.,Journal of Immunology,vol. 155, pp. 4749-4756 (1995).
D.D. Kharkevitch et al.,Int. J. Cancer,vol. 58, pp. 317-323 (1994).
Van Tsai et al.,Journal of Immunology,vol. 158, pp. 1796-1802 (1997).
John D. Altman et al.,Science,vol. 274, pp. 94-96 (1996).
Burgess et al., J. of Cell Bio. 111:2129-2138, (1990).
Lazar et al., Molecular and Cellular Biology 8:1247-152, (1988).
Bowie et al., Science, 247:1306-1310, (1990).
Gohara et al.,Jpn. J. Cancer Res.,vol. 88, pp. 198-402 (1997).
DNA Research 2, pp. 167-174 (1995).
Yotnda et al.,J. Clin. Invest.,vol. 102, No. 2, pp. 455-462 (1998).
Takahashi et al.,Cellular Immunology,vol. 178, pp. 162-171 (1997).
KIAA0156 (Genbank Accession No. D63879).
HLA-A2 cDNA (Genbank Accession No. M84379).
Thomson et al.,The Journal of Immunology,vol. 160, pp. 1717-1723 (1998).
Riott et al.,Immunology,Fourth Edition, pp. 7, 9-7 and 11 (1996).
Sherman, L.A. et al.,Critical Reviews in Immunol.,vol. 18, pp. 47-54 (1998).
Lauritzsen et al.,International Journal of Cancer,vol. 78, pp. 216-222 1998).
Sarma et al.,Journal of Experimental Medicine,vol. 189, pp. 811-820 (1999).
M. Nakao et al.;Cancer Research,vol. 55, pp. 4248-4252. (1955).
S.A. Rosenberg et al.,J. Nat'l. Cancer Inst.,vol. 86, pp. 1159-1166 (1994).

Affiliated with

Also associated with

Rating

Tumor antigen peptides derived from cyclophilin B does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor antigen peptides derived from cyclophilin B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor antigen peptides derived from cyclophilin B will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3914567